The insulin-like growth factor binding protein 3 ternary complex is reduced in cirrhosis

Liver

Volumn 21, Issue 5, 2001, Pages 350-356

  Ottesen, Lone Harild ^a,d   Bendtsen, Flemming ^b   Flyvbjerg, Allan ^c  

^a Center for Clinical Pharmacology   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

Acid labile subunit; Cirrhosis; IGF I; IGFBP 3; IGFBP 3 ternary complex

Indexed keywords

ACID LABILE SUBUNIT; GROWTH HORMONE; PROTEIN SUBUNIT; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; PROTEIN BINDING; PROTEIN DEGRADATION; SCORING SYSTEM;

ADULT; AGED; CARRIER PROTEINS; GLYCOPROTEINS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIVER CIRRHOSIS; MIDDLE AGED;

EID: 0034806424     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2001.210508.x     Document Type: Article

References (40)

1. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults
2. Use of leucine clamp to demonstrate that IGF-I actively stimulates protein synthesis in normal humans
3. Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3
4. Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex
5. Binding proteins for the insulin-like growth factors: Structure, regulation and function
6. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: Effects of IGF-I therapy on IGFBP-3
7. Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats
8. Growth hormone, insulin like growth factor-I, and insulin like growth factor binding proteins 1 and 3 in chronic liver disease
9. Concentrations, release and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBPs), IGF-I and growth hormone in different vascular beds in patients with cirrhosis
10. The insulin-like growth factor and binding protein axis in children with end-stage liver disease before and after orthotopic liver transplantation
11. The acid-labile subunit of the ternary insulin-like growth factor complex in cirrhosis: Relation to liver dysfunction
12. The liver: A large endocrine gland
13. Transection of the oesophagus for bleeding oesophageal varices
14. Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II
15. Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies
16. Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats
17. No effect of growth hormone on serum insulin-like growth factor binding protein-3 proteolysis
18. Reduced serum somatomedin activity in patients with chronic liver disease
19. Insulin-like growth factor I: A good indicator of functional hepatocellular capacity in alcoholic liver cirrhosis
20. Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease
21. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates
22. Insulin-like growth factor (IGF) and IGF-binding proteins: Comparison of human serum and lymph
23. Effects of alcohol and liver cirrhosis on the GH-IGF-I axis
24. Radioimmunoassay of serum IGF-I and IGF-II in patients with chronic liver disease and hepatocellular carcinoma with or without hypoglycemia
25. Resistance to the growth-promoting and metabolic effects of growth hormone in children with chronic liver disease
26. Insulin-like growth factor bioactivity and its modification in growth hormone resistant states
27. Absence of growth hormone receptor in hepatocellular carcinoma and cirrhotic liver
28. Decreased serum growth hormone-binding protein in patients with liver cirrhosis
29. Regulation of growth hormone (GH), insulin-like growth factor (IGF)I, IGF binding proteins-1, -2, -3 and GH binding protein during progression of liver cirrhosis
30. Endotoxin-induced inhibition of growth hormone receptor signaling in rat liver in vivo
31. Role of the suppressor of cytokine signaling-3 in mediating the inhibitory effects of interleukin-1beta on the growth hormone-dependent transcription of the acid-labile subunit gene in liver cells
32. The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness
33. IGF binding protein-3 protease regulation: How sweet it is!
34. Differential changes in free and total insulin-like growth factor I after major, elective abdominal surgery: The possible role of insulin-like growth factor-binding protein-3 proteolysis
35. Insulin-like growth factor (IGF)-binding proteins: Interactions with IGFs and intrinsic bioactivities
36. Changes in the circulating IGF system during short-term fasting and refeeding in rats
37. Coculture of primary rat hepatocytes and non-parenchymal cells permits expression of insulin-like growth factor binding protein-3 in vitro
38. Regulation in vivo of the acid-labile subunit of the rat serum insulin-like growth factor-binding protein complex
39. Differential cellular synthesis of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 within human liver
40. Determination of the hepatic galactose elimination capacity after a single intravenous injection in man. The reproducibility and the influence of uneven distribution